Because COX-2 is known to have the anti-apoptotic ability and over-expressed in colon cancer, the efficacy of ω3-PUFAs in inhibiting the expression of this enzyme seems to be the key to explaining the antitumor effect of these fatty acids in colon cancer [159]. Here, PTGS2 is linked to colonic neoplasm.